Advertisement
Advertisement

AMPH

AMPH logo

Amphastar Pharmaceuticals Inc

38.84
USD
-0.3
-0.77%
Dec 23, 14:59 UTC -5
Open

Amphastar Pharmaceuticals Inc Profile

About

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Info & Links

CEO

Jack Yongfeng Zhang

Headquarters

11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.amphastar.com

Auditor

Ernst & Young LLP

Share holders

120

Employees

1,761

Amphastar Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

1.87B

Enterprise Value

2.27B

Enterprise Value/EBITDA(ttm)

8.27

Price to Earnings Ratio(ttm)

11.38

Price to Sales(ttm)

2.62

Price to Book(mrq)

2.63

Price to Cash(ytd)

9.02

Profitability

Gross Margin(ttm)

52.98%

Operating Margin(ttm)

25.15%

Profit Margin(ttm)

21.85%

Return on Equity(ttm)

26.44%

Return on Invested Capital(ttm)

12.32%

Return on Assets(ttm)

11.89%

Income Statement

Revenue(ttm)

723.55M

Revenue Per Share(ttm)

15.05

Gross Profit(ttm)

383.35M

EBITDA(ttm)3

274.83M

Net Income Available to Common(ttm)

157.72M

Diluted EPS(ttm)

3.00

Share Statistics

Beta (5Y Monthly)

0.78

52-Week Change

-35.18%

S&P 500 52-Week Change

24.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

48.08M

Dividend Yield

0.00%

Float4

35.05M

% Held by Insiders

27.10%

% Held by Institutions

65.09%

Balance Sheet

Total Cash(mrq)

252.93M

Total Cash Per Share(mrq)

5.26

Total Debt(mrq)

596.70M

Total Debt/Equity(mrq)

82.00%

Current Ratio(mrq)

3.43%

Quick Ratio(mrq)

2.61%

Book Value Per Share(mrq)

15.04

Cash Flow

Operating Cash Flow Per Share(ytd)

3.55

Free Cash Flow(ytd)

155.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement